DEA’s 2021 Fentanyl Profiling Program Report

The U.S. Drug Enforcement Administration released its 2021 Fentanyl Profiling Program report examining trends in how and where the drug is being found. Here are some facts from the report about how fentanyl is being found in counterfeit pills.

[...]

DEA Warns that Counterfeit Pills and Fentanyl Continue to Threaten Americans

Each year, the U.S. Drug Enforcement Administration pools the knowledge of law enforcement agencies around the country to produce its National Drug Threat Assessment. This year, fentanyl, counterfeit prescription pills, and the pill presses are all listed as things that will continue to endanger American lives…

[...]

Website Operators Warned by FDA/DEA Offered Antibiotics, Cancer & HIV Treatments in Addition to Misbranded Opioids

On September 30th, the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) issued a joint warning to four online networks that were operating a total of ten fake online pharmacy websites. While all four networks were offering misbranded/counterfeit opioid medications such as tramadol and Soma for sale, three of the online networks had marketplaces offering misbranded medications to treat a kaleidoscope of ailments, such as allergies, cancer, smoking, asthma, and infection.

[...]